HFA Premium Access

FDA expedited access pathway enables staged approval opportunity for baroreflex activation therapy for heart failure with reduced ejection fraction: the BeAT-HF trial

Congress Session

About the speaker

Professor William Abraham

The Ohio State University, Columbus (United States of America)
39 presentations
2 followers

22 more presentations in this session

Could one-year effect of cardiac resynchronization therapy on hemodynamic parameters evaluated by impedance cardiography be predicted ?

Speaker: Mr M. Orszulak (Katowice, PL)

Thumbnail

A local network for refractory cardiogenic shock

Speaker: Doctor C. Sorini Dini (Siena, IT)

Thumbnail

Long-term survival and predictors of mortality in patients supported with a left ventricular assist device as destination therapy

Speaker: Doctor C. Kapelios (Salt Lake City, US)

Thumbnail

Single center long term results of mechanical circulatory support in the netherlands

Speaker: Doctor N. de Jonge (Utrecht, NL)

Thumbnail

Soluble ST2 levels in end-stage heart failure and during LVAD support

Speaker: Doctor N. de Jonge (Utrecht, NL)

Thumbnail

Access the full session

Poster Session 3 - Devices / CRT / ICD

Speakers: Professor W. Abraham, Mr M. Orszulak, Doctor C. Sorini Dini, Doctor C. Kapelios, Doctor N. de Jonge...
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk